Global Markets for Generic Drugs

Global Markets for Generic Drugs

Report Scope:

The report discusses the current size and growth of the market for generic drugs, both in global terms and broken down by the most important national markets. The report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It also covers the emerging trends in the generic drugs industry.

By geographical region, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the World. The North America region includes countries such as the U.S., Canada and Mexico; Europe includes Germany, U.K., Italy, and Rest of Europe; Asia-Pacific includes China, India, Japan, and Rest of Asia-Pacific. The estimated values used are based on drug manufacturers’ total revenues.

Report Includes:

37 data tables and 39 additional tables

An overview of the global markets for generic (pharmaceutical) drugs

Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Estimate of the market size and revenue forecast of the market for generic drugs, and corresponding market share analysis based on molecule type and geographic region

Evaluation of the current and future market potential of generic drugs, as well as the major generics, regulatory landscape and patent cliff within the biopharmaceutical industry

Discussion of the major market drivers, opportunities and challenges, emerging technologies, and regulations

Data and market value analyses for the U.S., Canada, Mexico, Germany, the U.K., Italy, China, India and Japan

Overview of the sustainability trends and factors in the market for generic drugs, with emphasis on consumer attitudes, ESG scores, case studies and the ESG practices of leading companies

Analysis of the pipeline for new generic drugs and their impact on the growth of the overall biopharmaceutical products market

Patent review and analysis of key patent grants

An analysis of the industry structure, including company market shares, recent M&A activity, and venture funding

Analysis of the top market players, their global rankings, recent developments, key financials and segmental revenues, and product portfolios

Profiles of the leading market players

Companies Mentioned

ASPEN PHARMACARE
AUROBINDO PHARMA
CIPLA INC.
DR. REDDY'S LABORATORIES LTD.
FRESENIUS KABI
LUPIN LTD.
SANDOZ
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC."